Eagle Pharmaceuticals Inc
|Market Cap (Intraday)||563.15M|
|2yr Forward PE||10.12|
Eagle Pharmaceuticals, Inc. Stock, NASDAQ:EGRX
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.